<p>Cells were pre-treated with 50 µM CQ for I hour and then treated with bortezomib for 24 to 48 hours. (A) Determining cell death by flow cytometry. After treatment, cells were stained with 10 µg/ml PI and PI positive cells were counted as died cells. Data represent mean ± SD from 3 independent experiments. Asterisk (*) indicates P<0.01, significantly increased sensitivity analyzed by ANOVA. (B) Synergistic effect of CQ on bortezomib. Synergy was analyzed by CalcuSyn and synergy level was setup lower than 0.9. (C) PARP cleavage. PARP cleavage was analyzed by Western blotting using polyclonal anti-PARP antibody (1∶500). Lower bands (89 kD) indicate cleaved PARP. (D) Cell death in primary FL and DLBCL cells. Primary cells from liquid nitroge...
(A) Ph+ cells BV-173 were seeded with DMSO, dasatinib 50nM, bortezomib 6.25nM and the combination at...
(A) Ph+ cells TOM-1 seeded with DMSO, dasatinib 50 nM, bortezomib 5 nM and the combination at day 0,...
<p>Evaluation of apoptosis through WB analysis of PARP cleavage (CL PARP = Cleaved PARP) (A) in MM ...
<p><b>A</b>. K562 leukemic cells were exposed to bortezomib (9nM) with or without paclitaxel (6nM) f...
<p>(A) Dose-response curve of bortezomib sensitivity in representative cell lines. The vertical axis...
<p><b>(A)</b> ACHN cells were treated with either nothing (C), 10 μM RAD001 (R), 100 μM HCQ (H) with...
<p>(A). Frequency of apoptosis of RPMI 8226 and AMO1. Left panels: dot plots showing the frequency o...
<p>Synergistic effect of K27 and bortezomib (BZ in the figure) (A, C, E, G) or CX-4945 and bortezomi...
<p>Su-DHL8 cells were treated with 20 nM bortezomib with or without 50 µg/ml of CQ. (A and B) Effect...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
S exposed only to vehicle at various doses of bortezomib, POH, or combination of both for 24 hours. ...
<p><b>A</b>. K562 leukemic cells were plated in 75cm<sup>2</sup> flasks (2 x 10<sup>6</sup> cells/30...
<p>JC1 staining and FACS analysis of MM cells (INA-6 or INA-6 cocoltured with HS-5 (A) or MCL cell l...
<p>Su-DHL-8 cells were pre-treated with 50 µg/ml CHX for 1 hour and then incubated with 20 nM bortez...
<p>Quantitative Real Time PCR analysis of NF-<b>κ</b>B <i>(IAP-2, TNFα, COX-2, IL-6, Bcl2, NOS-2</i>...
(A) Ph+ cells BV-173 were seeded with DMSO, dasatinib 50nM, bortezomib 6.25nM and the combination at...
(A) Ph+ cells TOM-1 seeded with DMSO, dasatinib 50 nM, bortezomib 5 nM and the combination at day 0,...
<p>Evaluation of apoptosis through WB analysis of PARP cleavage (CL PARP = Cleaved PARP) (A) in MM ...
<p><b>A</b>. K562 leukemic cells were exposed to bortezomib (9nM) with or without paclitaxel (6nM) f...
<p>(A) Dose-response curve of bortezomib sensitivity in representative cell lines. The vertical axis...
<p><b>(A)</b> ACHN cells were treated with either nothing (C), 10 μM RAD001 (R), 100 μM HCQ (H) with...
<p>(A). Frequency of apoptosis of RPMI 8226 and AMO1. Left panels: dot plots showing the frequency o...
<p>Synergistic effect of K27 and bortezomib (BZ in the figure) (A, C, E, G) or CX-4945 and bortezomi...
<p>Su-DHL8 cells were treated with 20 nM bortezomib with or without 50 µg/ml of CQ. (A and B) Effect...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
S exposed only to vehicle at various doses of bortezomib, POH, or combination of both for 24 hours. ...
<p><b>A</b>. K562 leukemic cells were plated in 75cm<sup>2</sup> flasks (2 x 10<sup>6</sup> cells/30...
<p>JC1 staining and FACS analysis of MM cells (INA-6 or INA-6 cocoltured with HS-5 (A) or MCL cell l...
<p>Su-DHL-8 cells were pre-treated with 50 µg/ml CHX for 1 hour and then incubated with 20 nM bortez...
<p>Quantitative Real Time PCR analysis of NF-<b>κ</b>B <i>(IAP-2, TNFα, COX-2, IL-6, Bcl2, NOS-2</i>...
(A) Ph+ cells BV-173 were seeded with DMSO, dasatinib 50nM, bortezomib 6.25nM and the combination at...
(A) Ph+ cells TOM-1 seeded with DMSO, dasatinib 50 nM, bortezomib 5 nM and the combination at day 0,...
<p>Evaluation of apoptosis through WB analysis of PARP cleavage (CL PARP = Cleaved PARP) (A) in MM ...